Efficacy and Duration of Action of the Four Selective Angiotensin II Subtype 1 Receptor Blockers, Losartan, Candesartan, Valsartan and Telmisartan, in Patients with Essential Hypertension Determined by Home Blood Pressure Measurements
- 1 January 2005
- journal article
- research article
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 27 (6) , 477-489
- https://doi.org/10.1081/ceh-200067668
Abstract
(2005). Efficacy and Duration of Action of the Four Selective Angiotensin II Subtype 1 Receptor Blockers, Losartan, Candesartan, Valsartan and Telmisartan, in Patients with Essential Hypertension Determined by Home Blood Pressure Measurements. Clinical and Experimental Hypertension: Vol. 27, No. 6, pp. 477-489.Keywords
This publication has 21 references indexed in Scilit:
- 2003 European Society of Hypertension???European Society of Cardiology guidelines for the management of arterial hypertension*Journal Of Hypertension, 2003
- Therapeutic effects of evening administration of guanabenz and clonidine on morning hypertensionJournal Of Hypertension, 2003
- Jananese Society of Hypertension (JSH) Guidelines for Self-Monitoring of Blood Pressure at HomeHypertension Research, 2003
- ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertensionJournal of Human Hypertension, 1999
- Ambulatory Pulse PressureHypertension, 1998
- Reproducibility and Clinical Value of the Trough-to-Peak Ratio of the Antihypertensive EffectHypertension, 1998
- Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurementJournal Of Hypertension, 1998
- Pulse PressureHypertension, 1997
- Calculation of trough: peak ratio of antihypertensive treatment from ambulatory blood pressure: methodological aspectsJournal Of Hypertension, 1995
- Clinical Significance and Cost-Effectiveness of 24-hour Ambulatory Blood Pressure Monitoring.The Tohoku Journal of Experimental Medicine, 1995